Pradefovir Experimental HBV Drug Pradefovir: Safety, Tolerability, Antiviral Activity, and Pharmacokinetics - 11/21/05 New Experimental HBV Drug Pradefovir from Valeant Pharmaceuticals Shows Promising 24-week Interim Results in Phase 2 Study - 7/22/05 Pradefovir, a New Agent for the Treatment of Chronic Hepatitis B - 4/22/05
